COPD patients tracked for a year on new triple inhaler
NCT ID NCT05862545
Summary
This study followed 250 Italian adults with moderate-to-severe COPD for up to one year after they started using the Trixeo triple-therapy inhaler in routine care. Researchers tracked changes in breathing symptoms, quality of life, and healthcare visits to understand how the treatment works in everyday life outside of controlled trials. The main goal was to see if patients felt better, particularly in the first 12 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Acquaviva delle Fonti, Italy
-
Research Site
Alessandria, Italy
-
Research Site
Ancona, Italy
-
Research Site
Avellino, Italy
-
Research Site
Brescia, Italy
-
Research Site
Brindisi, Italy
-
Research Site
Busto Arsizio (Varese), Italy
-
Research Site
Catania, Italy
-
Research Site
Catanzaro, Italy
-
Research Site
Cittadella (Padova), Italy
-
Research Site
Florence, Italy
-
Research Site
Foggia, Italy
-
Research Site
Lecce, Italy
-
Research Site
Naples, Italy
-
Research Site
Passirana (Milano), Italy
-
Research Site
Pavia, Italy
-
Research Site
Roma, Italy
-
Research Site
Torino, Italy
-
Research Site
Treviso, Italy
-
Research Site
Verona, Italy
Conditions
Explore the condition pages connected to this study.